AHR Stock Analysis: Buy, Sell, or Hold?

AHR - American Healthcare REIT, Inc.

REAL ESTATE INVESTMENT TRUSTS
$49.89
-1.25 (-2.44%) ▼
5d: -3.52%
30d: -1.36%
90d: -3.69%
HOLD
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 07, 2026 0d

Get Alerted When AHR Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: AHR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$42.00
Based on 12.9% avg growth
INTRINSIC VALUE TODAY
$26.08
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: AHR is currently trading at $49.89, which is considered extended relative to its 30-day fair value range of $48.64 to $50.93. The stock's valuation (Forward PE: 55.3) is in line with its historical norms (61.1). Remarkably, the market is currently pricing in an annual earnings decline of 3.3% over the next few years. This pessimistic expectation contrasts with the company's recent 306.2% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, AHR is in a strong uptrend. The price is currently testing key support at $48.94. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: AHR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $57.92 (+13.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $48.64 - $50.93
Company Quality Score 62/100 (BUY)
Volume Confirmation HIGH
Confidence Score 59.5%

All Signals

  • BEARISH: Price extended above range
  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($57.92)

Trading Range Analysis

30-Day Trading Range $48.64 - $50.93
Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $48.94
Resistance Level $52.45
Current Trend Strong Uptrend
Technical data as of May 14, 2026

Fundamental Context

Forward P/E (Next Year Est.) 55.29
Wall Street Target $57.92 (+13.3%)
Revenue Growth (YoY) 20.9%
Earnings Growth (YoY) 306.2%
Profit Margin 4.2%
Valuation Discount vs History -3.3% cheaper
PE vs Historical 55.3 vs 61.1 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -3.3% (market-implied from PE analysis)
1-Year Target $49.45 (-3%)
2-Year Target $47.82 (-7%)
3-Year Target $46.24 (-10%)
3-Yr Target (if PE normalizes) (PE: 55→61) $51.10 (0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 55.3, Growth: 21.7%) $92.20 (+80%)
Base: (SPY PE: 22.0, Growth: 21.7%) $36.76 (-28%)
Bear: (PE: 18.7, Growth: 21.7%) $31.24 (-39%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (62x PE), but valuation improves significantly next year (55x PE) as earnings recover.
Forward PE: 61.73 | Forward EPS (Implied): $0.83
Bull Case $61.75 (+21%)
Analyst growth 15.0%, PE expands to 64.8
Base Case $51.14 (0%)
Market implied 0.0%, PE stable at 61.7
Bear Case $39.12 (-24%)
Severe decline -15.0%, PE contracts to 55.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 55.3 to 61.1
Stabilization Target: $56.52 (+10.5%)
PE Expansion Potential: +10.5%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: May 15, 2026 10:13 AM ET
Data refreshes hourly during market hours. Next update: 11:13 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark E Foster SELL 2000 shares 2026-03-25
Jeffrey T Hanson SELL 19208 shares 2025-12-23
Jeffrey T Hanson SELL 35570 shares 2025-12-22

Unlock Insider Activity

See real-time buying/selling by company executives for AHR.

Create Free Account

Already have an account? Log In

Top Rated REIT - Healthcare Facilities Stocks

Top-rated stocks in REIT - Healthcare Facilities by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
VTR
Ventas Inc
STRONG BUY
20 analysts
$95 63 BUY
WELL
Welltower Inc
STRONG BUY
20 analysts
$233 63 BUY
DOC
Healthpeak Properties Inc
STRONG BUY
20 analysts
$20 58 HOLD
STRW
Strawberry Fields REIT L…
STRONG BUY
7 analysts
$15 62 BUY
CTRE
CareTrust REIT Inc.
STRONG BUY
9 analysts
$44 64 BUY

More Analysis for AHR

AHR Technical Chart AHR Price Prediction AHR Earnings Date AHR Investment Advisor AHR Fair Price Analyzer AHR Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals